(Q66406781)

English

Women at Risk of Breast Cancer and OLFM4

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

Evaluation of the Circulating Concentration of Olfactomédine 4 (OLFM4) in Women With a BRCA1 or 2 Gene Mutation or at High Risk of Developing Breast Cancer, According to the Imaging (English)
0 references
0 references
8 March 2016
0 references
February 2026
0 references
300
0 references
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit